Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

STEVEN D NATHAN

Allopathic & Osteopathic Physicians Internal Medicine Pulmonary Disease

NPI
1891724134
CMS profile
176852
Location
FALLS CHURCH, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$179,015.06

199 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

STEVEN D NATHAN

NPI 1891724134 · CMS profile ID 176852

Allopathic & Osteopathic Physicians / Internal Medicine / Pulmonary Disease

FALLS CHURCH, VA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1891724134?year=2023&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
STEVEN D NATHAN, NPI 1891724134, CMS profile ID 176852. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1891724134?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). STEVEN D NATHAN, NPI 1891724134, CMS profile ID 176852. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1891724134?year=2023&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
STEVEN D NATHAN, NPI 1891724134, CMS profile ID 176852, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–199 of 199 matching records. This page contains 49 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1891724134?year=2023&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

199 matching records · $179,015.06 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 199 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–199 of 199.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
United Therapeutics Corporation $94.5703/01/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050966935 CMS
United Therapeutics Corporation $5.0002/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050946135 CMS
United Therapeutics Corporation $11.6002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050946785 CMS
United Therapeutics Corporation $15.0002/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050948351 CMS
United Therapeutics Corporation $31.8102/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050963027 CMS
United Therapeutics Corporation $92.7002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050966851 CMS
United Therapeutics Corporation $155.0002/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050969509 CMS
United Therapeutics Corporation $9,030.2502/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050972091 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $450.8202/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994617 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $499.0602/26/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994621 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $39.9202/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994631 CMS
Insmed, Inc. $21.8202/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 978789033 CMS
AstraZeneca UK Limited $697.5002/21/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017087103 CMS
AstraZeneca UK Limited $850.9502/17/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1016987911 CMS
AstraZeneca UK Limited $697.5002/17/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1017090947 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.6502/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1000680173 CMS
United Therapeutics Corporation $51.9502/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050965125 CMS
United Therapeutics Corporation $250.8902/10/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050969891 CMS
United Therapeutics Corporation $1,420.0002/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971139 CMS
United Therapeutics Corporation $4,300.0002/08/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971837 CMS
United Therapeutics Corporation $22.2902/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050955931 CMS
United Therapeutics Corporation $99.9502/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050967191 CMS
United Therapeutics Corporation $8.0202/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050946501 CMS
United Therapeutics Corporation $10.0002/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050946685 CMS
United Therapeutics Corporation $13.1002/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050947151 CMS
United Therapeutics Corporation $32.8402/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050963301 CMS
United Therapeutics Corporation $58.0002/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050965375 CMS
United Therapeutics Corporation $161.9102/02/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050969533 CMS
United Therapeutics Corporation $1,420.0001/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971141 CMS
United Therapeutics Corporation $2,500.0001/30/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971437 CMS
United Therapeutics Corporation $21.3201/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050954871 CMS
United Therapeutics Corporation $3,400.0001/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050971723 CMS
United Therapeutics Corporation $18.6401/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050951993 CMS
United Therapeutics Corporation $23.3401/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050957477 CMS
United Therapeutics Corporation $87.5701/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050966603 CMS
United Therapeutics Corporation $720.3701/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050970731 CMS
United Therapeutics Corporation $10.0001/13/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050946683 CMS
United Therapeutics Corporation $15.0001/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050948465 CMS
United Therapeutics Corporation $83.7101/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050966423 CMS
United Therapeutics Corporation $256.5601/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050969897 CMS
United Therapeutics Corporation $587.7201/11/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050970623 CMS
United Therapeutics Corporation $38.0001/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050964157 CMS
United Therapeutics Corporation $429.8001/06/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050970419 CMS
United Therapeutics Corporation $490.0001/05/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050970515 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $1,270.0001/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994657 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $35.0001/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994659 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $6,350.0001/03/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994665 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $140.0001/03/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996994669 CMS
Vertex Pharmaceuticals Incorporated $25.7701/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1013442763 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $322,891.14 242
PY2020 $142,040.59 75
PY2021 $171,884.64 133
PY2022 $179,376.27 188
PY2023 $179,015.06 199
PY2024 $230,136.68 273
PY2025 $240,519.64 248

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $48,337.42 23
PY2025 Principal investigator $427,790.27 42
PY2024 Recipient $28,398.06 19
PY2024 Principal investigator $136,216.94 37
PY2023 Recipient $34,006.85 13
PY2023 Principal investigator $17,000.00 2
PY2022 Recipient $5,891.48 7
PY2021 Recipient $21,572.43 25
PY2021 Principal investigator $229,978.00 2
PY2020 Recipient $34,954.02 20
PY2020 Principal investigator $25,682.76 1
PY2019 Principal investigator $151,835.32 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

65 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Recipient United Therapeutics Corporation $860.64 12/24/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380128
Recipient United Therapeutics Corporation $6,026.86 12/24/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380132
Recipient United Therapeutics Corporation $1,102.50 12/24/2025 Covered Recipient Physician Tyvaso SMI (Soft Mist Inhaler)/treprostinil inhalation spray for the treatment of PH-COPD No dispute reported 06/30/2026 1242380140
Recipient ABBVIE INC. $650.00 12/15/2025 Covered Recipient Physician Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1202400199
Principal investigator 1 United Therapeutics Corporation $500.00 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381236
Principal investigator 1 United Therapeutics Corporation $630.00 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381238
Principal investigator 1 United Therapeutics Corporation $1,868.86 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381256
Principal investigator 1 United Therapeutics Corporation $2,359.80 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381262
Principal investigator 1 United Therapeutics Corporation $3,819.93 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381268
Principal investigator 1 United Therapeutics Corporation $5,432.03 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381274
Principal investigator 1 United Therapeutics Corporation $7,639.86 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381282
Principal investigator 1 United Therapeutics Corporation $12,150.00 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381296
Principal investigator 1 United Therapeutics Corporation $24,300.00 12/02/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381308
Recipient ABBVIE INC. $2,925.00 11/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400191
Recipient ABBVIE INC. $1,950.00 11/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400195
Principal investigator 1 United Therapeutics Corporation $210.00 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381232
Principal investigator 1 United Therapeutics Corporation $458.20 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381234
Principal investigator 1 United Therapeutics Corporation $1,000.00 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381246
Principal investigator 1 United Therapeutics Corporation $5,606.58 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381276
Principal investigator 1 United Therapeutics Corporation $12,179.28 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381298
Principal investigator 1 United Therapeutics Corporation $14,158.80 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381300
Principal investigator 1 United Therapeutics Corporation $30,559.44 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381310
Principal investigator 1 United Therapeutics Corporation $97,200.00 11/07/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381314
Recipient United Therapeutics Corporation $7,522.42 10/22/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380138
Recipient ABBVIE INC. $325.00 10/15/2025 Covered Recipient Physician Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1202400182
Recipient ABBVIE INC. $2,112.50 10/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400186
Principal investigator 1 United Therapeutics Corporation $4,059.76 10/06/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381270
Recipient ABBVIE INC. $1,625.00 09/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400179
Principal investigator 1 United Therapeutics Corporation $934.43 09/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381244
Principal investigator 1 United Therapeutics Corporation $15,279.72 09/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381302
Principal investigator 1 United Therapeutics Corporation $36,450.00 09/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381312
Recipient ABBVIE INC. $1,300.00 08/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400171
Recipient ABBVIE INC. $2,275.00 08/15/2025 Covered Recipient Physician Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1202400175
Recipient United Therapeutics Corporation $475.00 08/13/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380126
Recipient ABBVIE INC. $650.00 07/15/2025 Covered Recipient Physician Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1202400162
Recipient ABBVIE INC. $650.00 07/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400167
Recipient United Therapeutics Corporation $1,187.50 07/08/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380130
Principal investigator 1 United Therapeutics Corporation $1,868.86 07/04/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381252
Principal investigator 1 United Therapeutics Corporation $7,639.86 07/04/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381278
Principal investigator 1 United Therapeutics Corporation $12,150.00 07/04/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381292
Recipient ABBVIE INC. $1,950.00 06/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400154
Recipient ABBVIE INC. $650.00 06/15/2025 Covered Recipient Physician Study to Evaluate Adverse Events Change in Disease Activity and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab Cisplatin or Carboplatin in Adult Participants With Advanced Solid Tumors No dispute reported 06/30/2026 1202400158
Principal investigator 1 United Therapeutics Corporation $934.43 06/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381240
Principal investigator 1 United Therapeutics Corporation $2,359.80 06/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381258
Principal investigator 1 United Therapeutics Corporation $3,819.93 06/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381264
Principal investigator 1 United Therapeutics Corporation $12,150.00 06/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381294
Principal investigator 1 United Therapeutics Corporation $9,434.74 05/29/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381288
Recipient ABBVIE INC. $325.00 05/15/2025 Covered Recipient Physician Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 No dispute reported 06/30/2026 1202400150
Principal investigator 1 United Therapeutics Corporation $934.43 05/15/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381242
Principal investigator 1 United Therapeutics Corporation $1,435.00 05/15/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381248
Principal investigator 1 United Therapeutics Corporation $1,500.00 05/15/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381250
Principal investigator 1 United Therapeutics Corporation $3,819.93 05/15/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381266
Principal investigator 1 United Therapeutics Corporation $24,300.00 05/15/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381306
Principal investigator 1 United Therapeutics Corporation $1,868.86 05/08/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381254
Principal investigator 1 United Therapeutics Corporation $2,359.80 05/08/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381260
Principal investigator 1 United Therapeutics Corporation $7,639.86 05/08/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381280
Principal investigator 1 United Therapeutics Corporation $24,300.00 05/08/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381304
Recipient United Therapeutics Corporation $475.00 05/07/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380124
Principal investigator 1 United Therapeutics Corporation $10,864.06 05/05/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381290
Principal investigator 1 United Therapeutics Corporation $8,119.52 04/04/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381284
Recipient United Therapeutics Corporation $6,104.44 03/12/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380134
Recipient United Therapeutics Corporation $6,720.56 03/12/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380136
Principal investigator 1 United Therapeutics Corporation $8,119.52 03/06/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381286
Recipient United Therapeutics Corporation $475.00 02/12/2025 Covered Recipient Physician A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis No dispute reported 06/30/2026 1242380122
Principal investigator 1 United Therapeutics Corporation $5,374.98 01/09/2025 Covered Recipient Teaching Hospital
Inova Loudoun Hospital Center
PULMONARY HYPERTENSION SCREENING IN PATIENTS WITH INTERSTITIAL LUNG DISEASE FOR EARLIER DETECTION (PHINDER) No dispute reported 06/30/2026 1242381272